Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholestimide for refractory functional dyspepsia
jRCTs031200347Phase 2Completed
- Sponsor
- Yokohama City University
- Start
- Feb 2021
- Modality
- Small Molecules, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cholestyramine in functional dyspepsia (FD), sponsored by Yokohama City University. Primary endpoint: Overall treatment efficacy at 4 weeks. Started Feb 2021; status: completed.
02
Drugs
cholestyramine
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on jRCTs031200347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200347.